Long-term Effects of the Oral Adsorbent, AST-120, in Patients with Chronic Renal Failure

By Maeda K   Hamada C   Hayashi T   Shou I   Wakabayashi M   Fukui M   Horikoshi S   Tomino Y  

The Journal of International Medical Research, Vol. 37, Iss. 1, 2009-01 ,pp. : 205-213

Field House Publishing

Access to resources Recommend Favorite

An Oral Adsorbent, AST-120 Protects Against the Progression of Oxidative Stress by Reducing the Accumulation of Indoxyl Sulfate in the Systemic Circulation in Renal Failure

By Shimoishi Kazuki   Anraku Makoto   Kitamura Kenichiro   Tasaki Yuka   Taguchi Kazuaki   Hashimoto Mitsuru   Fukunaga Eiko   Maruyama Toru   Otagiri Masaki  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1283-1289

Springer Publishing Company

Access to resources Recommend Favorite

The oral adsorbent, AST 120 [Kremezin; Kureha Chemical], has been approved in South Korea

By  

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

By Spigset Olav   Hägg Staffan   Stegmayr Bernd   Dahlqvist Rune  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 699-703

Springer Publishing Company

Access to resources Recommend Favorite

Dose-Dependent Effect of Aprotinin on Aggravated Pro-Inflammatory Cytokines in Patients with Pulmonary Hypertension Following Cardiopulmonary Bypass

By Lei Ye   Haider Husnain Kh.   Chusnsheng Wang   Zhiqiang Cheng   Hao Chen   Kejian Hu   Qiang Zhao  

Cardiovascular Drugs and Therapy, Vol. 17, Iss. 4, 2003-07 ,pp. : 343-348

Springer Publishing Company

Access to resources Recommend Favorite